1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys

      ,
      Current Eye Research
      Informa UK Limited

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The ergoline derivatives, bromocriptine, lergotrile and pergolide, are potent dopaminergic agonists. Topically administered doses of lergotrile and pergolide, ranging from 0.001 to 1% applied unilaterally, produced dose and time-related ocular hypotension in rabbits and monkeys. In contrast, bromocriptine produced moderate ocular hypotension in rabbits but not in monkeys. Lergotrile (1%) produced significant mydriasis in rabbits whereas pergolide (0.01 to 0.1%) produced a slight miosis. Lergotrile and pergolide were also effective in suppressing ocular hypertension induced by water loading in rabbits whereas bromocriptine was relatively ineffective. These data demonstrate that topically administered ergoline derivatives can: 1) lower intraocular pressure in rabbits and monkeys, 2) suppress ocular hypertension induced by water loading in rabbits and 3) alter iris function in rabbits, producing either mydriasis or miosis, presumably by activation of adrenoceptors.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bromocriptine in Parkinsonism.

            Bromocriptine, a drug acting directly upon dopaminergic receptors, has been found to have a significant therapeutic action in a double-blind study of 20 patients with idiopathic Parkinsonism who were already receiving conventional therapy, including levodopa. Neurological deficits improved by almost 20% in severely disabled patients; amelioration of mildly affected patients was about 10%. Adverse reactions were similar to those encountered with levodopa-they were all dose-dependent and reversible. These observations are discussed in relation to certain theoretical advantages which might be expected from a drug which acts directly on dopaminergic receptors.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.

              Dopamine receptor activation can lead to pronounced changes in cardiovascular function. The myriad of effects produced by dopamine receptor agonists results from the activation of dopamine receptors located at different anatomical sites in the cardiovascular system. Further basic research is required to better characterize these dopamine receptors so as to allow the development of more specific dopamine receptor agonists. Endogenous dopamine may be involved in the physiological control of fluid and electrolyte balance and continuing research efforts in this area should provide for a better understanding of the role of cardiovascular dopamine receptors in the maintenance of overall circulatory homeostasis. Cardiovascular dopamine receptor stimulation represents an important and promising approach for the development of novel therapeutic agents for the treatment of hypertension, angina pectoris, congestive heart failure and acute renal failure.
                Bookmark

                Author and article information

                Journal
                Current Eye Research
                Current Eye Research
                Informa UK Limited
                0271-3683
                1460-2202
                July 02 2009
                January 1982
                July 02 2009
                January 1982
                : 2
                : 5
                : 281-288
                Article
                10.3109/02713688209000771
                6131794
                16664736-e863-49df-83a5-577d5106217e
                © 1982
                History

                Comments

                Comment on this article